FAQ

Valneva

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2015-2017
01220152017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Influenza viruses production: Evaluation of a novel avian cell line DuckCelt®-T17.
The influenza vaccine manufacturing industry is looking for production cell lines that are easily scalable, highly permissive to… (More)
Is this relevant?
2017
2017
Immunogenicity of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children From a Japanese Encephalitis Virus-endemic Region.
BACKGROUND Japanese encephalitis (JE) is a major public health concern in Asia and poses a small but potentially fatal threat to… (More)
Is this relevant?
2017
2017
Safety of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children: An Open-label, Randomized, Active-controlled, Phase 3 Study.
BACKGROUND Japanese encephalitis remains a serious health concern in Asian countries and has sporadically affected pediatric… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2016
2016
Re-born in the USA: Another cholera vaccine for travellers.
Vaxchora (oral live attenuated cholera vaccine [CVD 103HgR]; PaxVax), expected to be available in the U.S. in September 2016 at… (More)
Is this relevant?
2015
2015
Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis.
BACKGROUND Japanese Encephalitis (JE) virus occurs in wide regions of Asia with over 3 billion people living in areas at risk for… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 4
Is this relevant?
2015
2015
Evaluation of rabies immunogenicity and tolerability following a purified chick embryo cell rabies vaccine administered concomitantly with a Japanese encephalitis vaccine.
BACKGROUND For individuals traveling at short notice to rabies and Japanese encephalitis (JE) endemic countries, concomitant… (More)
Is this relevant?